Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Brown, Jennifer R., Eichhorst, Barbara, Ghia, Paolo, Kater, A. P., Li, Jianyong, Khurana, Sudha, Elhamy, Mostafa, Wang, Min Hui and Seymour, John F. (2020). Phase 3 Trial of Acalabrutinib in Combination with Venetoclax, With and Without Obinutuzumab Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia (CLL). Clin. Lymphoma Myeloma Leuk., 20. S. S221 - 2. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

Eichhorst, B., Robak, T., Montserrat, E., Ghia, P., Niemann, C. U., Kater, A. P., Gregor, M., Cymbalista, F., Buske, C., Hillmen, P., Hallek, M. and Mey, U. (2021). Chronic lymohocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 32 (1). S. 23 - 34. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Fuerstenau, M., Fink, A-M, Herling, C., Maurer, C., Kutsch, N., de la Serna, J., Coscia, M., Eckert, R., Crespo, M., Bosch, F., Noesslinger, T., Ghia, P., Kater, A. P., Boettcher, S., Ritgen, M., Schilhabel, A., Stilgenbauer, S., Tausch, E., Fischer, K., Hallek, M. and Eichhorst, B. (2018). B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide. Oncol. Res. Treat., 41. S. 172 - 174. BASEL: KARGER. ISSN 2296-5262

Loeschcke, K., Fink, A., Bahlo, J., Westermann, A., Zey, A., Fischer, K., Wendtner, C. M., Noesslinger, T., Ghia, P., Bosch, F., Kater, A. P., Kreuzer, K. A., Stilgenbauer, S., Boettcher, S., Eichhorst, B. and Hallek, M. (2014). CENTRAL SCREENING ENABLES IDENTIFICATION OF HIGH RISK CLL PATIETNS FOR LENALIDOMIDE MAINTENANCE THERAPY WITHIN THE CLLM1 TRIAL OF THE GERMAN CLL STUDY GROUP. Haematologica, 99. S. 587 - 589. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Rawstron, A. C., Fazi, C., Agathangelidis, A., Villamor, N., Letestu, R., Nomdedeu, J., Palacio, C., Stehlikova, O., Kreuzer, K-A, Liptrot, S., O'Brien, D., de Tute, R. M., Marinov, I., Hauwel, M., Spacek, M., Dobber, J., Kater, A. P., Gambell, P., Soosapilla, A., Lozanski, G., Brachtl, G., Lin, K., Boysen, J., Hanson, C., Jorgensen, J. L., Stetler-Stevenson, M., Yuan, C., Broome, H. E., Rassenti, L., Craig, F., Delgado, J., Moreno, C., Bosch, F., Egle, A., Doubek, M., Pospisilova, S., Mulligan, S., Westerman, D., Sanders, C. M., Emerson, R., Robins, H. S., Kirsch, I., Shanafelt, T., Pettitt, A., Kipps, T. J., Wierda, W. G., Cymbalista, F., Hallek, M., Hillmen, P., Montserrat, E. and Ghia, P. (2016). A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study. Leukemia, 30 (4). S. 929 - 937. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Seymour, J. F., Kipps, T. J., Eichhorst, B., Hillmen, P., D'Rozario, J., Assouline, S., Owen, C., Gerecitano, J., Robak, T., De la Serna, J., Jaeger, U., Cartron, G., Montillo, M., Humerickhouse, R., Punnoose, E. A., Li, Y., Boyer, M., Humphrey, K., Mobasher, M. and Kater, A. P. (2018). Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia. N. Engl. J. Med., 378 (12). S. 1107 - 1121. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

This list was generated on Thu Mar 28 17:05:44 2024 CET.